ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
碧美斯
57.25
+0.0000
成交量:
- -
成交额:
- -
市值:
52.22亿
市盈率:
22.68
高:
57.25
开:
57.25
低:
57.25
收:
57.25
数据加载中...
总览
公司
新闻
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻
BMS拿下CAR-T明星公司!诺华、强生/传奇、吉利德等如何接招?
医药经济报
·
03-14
Flux Power Holdings, Inc.盘中异动 大幅拉升5.34%
市场透视
·
03-12
2Seventy Bio, Inc.股价拉升76.07% 市值涨1.93亿美元
市场透视
·
03-11
BMS 2.86亿美元收购2seventy,蓝鸟彻底“坠落”
新浪医药
·
03-11
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BMS"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","market":"US","secType":"STK","nameCN":"碧美斯","latestPrice":57.25,"timestamp":1569009600000,"preClose":57.25,"halted":0,"volume":0,"delay":0,"changeRate":0,"change":0,"floatShares":90294980,"shares":91211989,"eps":2.609607,"lyrEps":2.480219,"pbRate":4.18,"amount":0,"amplitude":0,"dividePrice":1.28,"prevYearClose":57.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","floatShares":90294980,"roa":"--","roe":"--","lyrEps":2.480219,"shares":91211990,"dividePrice":1.28,"high":57.25,"amplitude":0,"preClose":57.25,"low":57.25,"week52Low":40.86,"pbRate":"4.18","week52High":59.85,"institutionHeld":0.7014,"latestPrice":57.25,"eps":2.5238,"divideRate":0.022358,"volume":0,"delay":0,"ttmEps":2.5238,"open":57.25,"prevYearClose":57.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-01-29","symbol":"BMS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1580274000000,"reportTimeType":"pre","actualEps":null},{"date":"2019-10-23","symbol":"BMS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1571817600000,"name":null,"time":"盘前","dateTimestamp":1571803200000,"actualEps":null},{"market":"US","date":"2019-04-26","symbol":"BMS","amount":0.32,"name":"碧美斯","payableDate":"2019-04-29","currency":"USD","type":"dividend","dateTimestamp":1556251200000},{"market":"US","date":"2019-04-22","symbol":"BMS","fiscalQuarterEnding":"2019/03","expectedEps":0.66,"name":null,"time":"","type":"earning","dateTimestamp":1555905600000,"reportTimeType":"","actualEps":0.67},{"market":"US","date":"2019-02-19","symbol":"BMS","amount":0.32,"name":"碧美斯","currency":"USD","type":"dividend","dateTimestamp":1550552400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMS\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-16","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-05-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-08-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-11-14","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2018-02-16","recordDate":null,"paymentDate":null,"value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BMS\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519104814","title":"BMS拿下CAR-T明星公司!诺华、强生/传奇、吉利德等如何接招?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519104814","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519104814?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 11:41","pubTimestamp":1741923700,"startTime":"0","endTime":"0","summary":"当地时间3月11日,BMS以总股权价值2.86亿美元收购2seventy公司,将双方联合开发的BCMA CAR-T细胞疗法完全纳入旗下。Abecma是BMS第二款CAR-T细胞产品。此次收购,彰显了BMS在CAR-T疗法领域的决心,也代表2seventy的完美谢幕。Abecma是BMS第二款CAR-T疗法,也是首款获得FDA批准的BCMA CAR-T疗法,获批时间为2021年3月26日,用于治疗四线以上多发性骨髓瘤。作为BMS首个上市的CAR-T产品,Breyanzi一直表现良好。面对BMS的强攻态势,诺华、吉利德、强生等又将如何应对?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314114401ab64df8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314114401ab64df8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2129689605.HKD","NVS","IE0034235303.USD","LU1585245621.USD","BMS","IE00BKVL7J92.USD","LU1066051498.USD","BK4566","LU2129689514.USD","LU1718418525.SGD","LU2430703251.USD","LU1032466523.USD","BK4581","IE0002270589.USD","LU1267930813.SGD","LU1061106388.HKD","LU1732799900.SGD","CAR","LU2505996509.AUD","LU2592432038.USD","LU0203345920.USD","LU1506573853.SGD","BK4550","LU0889565916.HKD","LU1162221912.USD","LU2468319806.SGD","GILD","IE00B7SZLL34.SGD","LU0889566641.SGD","LU0122379950.USD","LU0345769631.USD","BK4007","LU1894683264.USD","LU1929549753.HKD","IE00B4R5TH58.HKD","JNJ","IE00BJJMRZ35.SGD","LU0795875086.SGD","IE00B1BXHZ80.USD","LU0208291251.USD","LU1066053197.SGD","LU1839511570.USD","LU2347655156.SGD","LU0792757196.USD","BK4139","LU0882574055.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU1280957306.USD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2518211207","title":"Flux Power Holdings, Inc.盘中异动 大幅拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518211207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518211207?lang=zh_cn&edition=fundamental","pubTime":"2025-03-12 00:14","pubTimestamp":1741709663,"startTime":"0","endTime":"0","summary":"北京时间2025年03月12日00时14分,Flux Power Holdings, Inc.股票出现波动,股价大幅拉升5.34%。Flux Power Holdings, Inc.股票所在的电气设备零件行业中,整体涨幅为1.65%。Flux Power Holdings, Inc.公司简介:Flux Power Holdings Inc设计、开发、制造和销售一系列锂离子储能解决方案,用于一系列工业和商业领域的电气化,包括物料处理、机场地面支持设备和其他商业和工业应用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312001423ab5e2473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250312001423ab5e2473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMS","BK4096","FLUX"],"gpt_icon":0},{"id":"2518741971","title":"2Seventy Bio, Inc.股价拉升76.07% 市值涨1.93亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518741971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518741971?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 21:30","pubTimestamp":1741699824,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日21时30分,2Seventy Bio, Inc.股票出现异动,股价大幅拉升76.07%。2Seventy Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。2Seventy Bio, Inc.公司简介:2seventy bio Inc 是一家细胞和基因治疗公司,专注于癌症变革性治疗的研究、开发和商业化。此次收购也标志着2seventy bio旅程的终结,蓝鸟彻底“坠落”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213025ab5de810&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213025ab5de810&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMS","TSVT","BK4139"],"gpt_icon":0},{"id":"2518745656","title":"BMS 2.86亿美元收购2seventy,蓝鸟彻底“坠落”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745656","media":"新浪医药","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518745656?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 19:55","pubTimestamp":1741694122,"startTime":"0","endTime":"0","summary":"交易预计将在2025年第二季度完成。2seventy bio管线中有多款CAR-T细胞疗法产品,其中Abecma由BMS合作开发和商业化,已在2021年获批上市。据BMS财报,2024年Abecma销售额为4.06亿美元。2024年6月时2seventy bio宣布,诺和诺德已经花费4000万美元购买了2seventy bio的血友病A项目,以及该生物技术用于自身免疫疾病的一些基因编辑技术的权利。作为与BMS推出BCMA-CAR-T Abecma的业内先驱,2seventy在两次业务出售后,也只剩下了 Abecma本身。此次收购也标志着2seventy bio旅程的终结,蓝鸟彻底“坠落”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311202840a1d4fe39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311202840a1d4fe39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BMS","BK4139","TSVT"],"gpt_icon":0}],"pageSize":4,"totalPage":26,"pageCount":1,"totalSize":104}]}}